Regulation of age-associated B cells by IRF5 in systemic autoimmunity

Nature Immunology

Volumn 19, Issue 4, 2018, Pages 407-419

  Manni, Michela ^a   Gupta, Sanjay ^a   Ricker, Edd ^b   Chinenov, Yurii ^a   Park, Sung Ho ^a   Shi, Man ^a   Pannellini, Tania ^a   Jessberger, Rolf ^c   Ivashkiv, Lionel B ^a,b,d   Pernis, Alessandra B ^a,b,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Weill Cornell Medical Center   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD11B ANTIGEN; CD19 ANTIGEN; CD23 ANTIGEN; CD86 ANTIGEN; DEF6 PROTEIN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SWAP 70 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR T BET; TRANSCRIPTOME; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, MOUSE; MINOR HISTOCOMPATIBILITY ANTIGEN; NUCLEAR PROTEIN; SLAT PROTEIN, MOUSE; SWAP70 PROTEIN, MOUSE;

AGE ASSOCIATED B CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FEMALE; IMMUNOREGULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; ANIMAL; B LYMPHOCYTE SUBPOPULATION; C57BL MOUSE; DEFICIENCY; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; DNA-BINDING PROTEINS; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINOR HISTOCOMPATIBILITY ANTIGENS; NUCLEAR PROTEINS;

EID: 85042555344     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-018-0056-8     Document Type: Article

References (53)

1. Liu, Z. &Davidson, A. Taming lupus-A new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18, 871-882 (2012).
2. Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305-1315 (2011).
3. Hao, Y., O'Neill, P., Naradikian, M. S., Scholz, J. L. &Cancro, M. P. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118, 1294-1304 (2011).
4. Naradikian, M. S., Hao, Y. &Cancro, M. P. Age-associated B cells: key mediators of both protective and autoreactive humoral responses. Immunol. Rev. 269, 118-129 (2016).
5. Naradikian, M. S. et al. Cutting Edge: IL-4, IL-21, and IFN-γ interact to govern T-bet and CD11c expression in TLR-activated B cells. J. Immunol. 197, 1023-1028 (2016).
6. Rubtsova, K., Rubtsov, A. V., van Dyk, L. F., Kappler, J. W. &Marrack, P. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc. Natl. Acad. Sci. USA 110, E3216-E3224 (2013).
7. Russell Knode, L. M. et al. Age-associated B cells express a diverse repertoire of VH and Vκ genes with somatic hypermutation. J. Immunol. 198, 1921-1927 (2017).
8. Rubtsov, A. V., Rubtsova, K., Kappler, J. W. &Marrack, P. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol. Res. 55, 210-216 (2013).
9. Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178, 6624-6633 (2007).
10. Sanz, I., Wei, C., Lee, F. E. &Anolik, J. Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 20, 67-82 (2008).
11. Rubtsova, K. et al. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J. Clin. Invest. 127, 1392-1404 (2017).
12. Rogatsky, I., Chandrasekaran, U., Manni, M., Yi, W. &Pernis, A. B. Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity. Autoimmunity 47, 242-255 (2014).
13. Matta, B., Song, S., Li, D. &Barnes, B. J. Interferon regulatory factor signaling in autoimmune disease. Cytokine 98, 15-26 (2017).
14. Murphy, T. L., Tussiwand, R. &Murphy, K. M. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 13, 499-509 (2013).
15. Lazzari, E. &Jefferies, C. A. IRF5-mediated signaling and implications for SLE. Clin. Immunol. 153, 343-352 (2014).
16. Cham, C. M., Ko, K. &Niewold, T. B. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin. Dev. Immunol. 2012, 780436 (2012).
17. Yasuda, K. et al. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. PLoS One 9, e103478 (2014).
18. Ban, T. et al. Lyn kinase suppresses the transcriptional activity of IRF5 in the TLR-MyD88 pathway to restrain the development of autoimmunity. Immunity 45, 319-332 (2016).
19. Savitsky, D. A., Yanai, H., Tamura, T., Taniguchi, T. &Honda, K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl. Acad. Sci. USA 107, 10154-10159 (2010).
20. Watkins, A. A. et al. IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupusassociated atherosclerosis. J. Immunol. 194, 1467-1479 (2015).
21. Ikushima, H., Negishi, H. &Taniguchi, T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol. 78, 105-116 (2013).
22. Shen, H. et al. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J. Mol. Cell Biol. 2, 284-290 (2010).
23. Fang, C. M. et al. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun. 13, 421-430 (2012).
24. Hotfilder, M., Baxendale, S., Cross, M. A. &Sablitzky, F. Def-2,-3,-6 and-8, novel mouse genes differentially expressed in the haemopoietic system. Br. J. Haematol. 106, 335-344 (1999).
25. Tanaka, Y. et al. SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 18, 403-414 (2003).
26. Gupta, S. et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum. Immunol. 64, 389-401 (2003).
27. Borggrefe, T., Wabl, M., Akhmedov, A. T. &Jessberger, R. A B-cell-specific DNA recombination complex. J. Biol. Chem. 273, 17025-17035 (1998).
28. Bécart, S. SpringerAmpamp; Altman, A. SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells. Immunol. Rev 232, 319-333 (2009).
29. Biswas, P. S., Bhagat, G. &Pernis, A. B. IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol. Rev. 233, 79-96 (2010).
30. Ripich, T. et al. SWEF proteins distinctly control maintenance and differentiation of hematopoietic stem cells. PLoS One 11, e0161060 (2016).
31. Sun, C. et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat. Genet. 48, 323-330 (2016).
32. Biswas, P. S. et al. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. J. Exp. Med. 209, 581-596 (2012).
33. Vinuesa, C. G. &Chang, P. P. Innate B cell helpers reveal novel types of antibody responses. Nat. Immunol. 14, 119-126 (2013).
34. Cannons, J. L., Tangye, S. G. &Schwartzberg, P. L. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29, 665-705 (2011).
35. Buenrostro, J. D., Wu, B., Chang, H. Y. &Greenleaf, W. J. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21-29 (2015).
36. Chen, Q. et al. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 29, 899-911 (2008).
37. Manni, M. et al. IRF4-dependent and IRF4-independent pathways contribute to DC dysfunction in lupus. PLoS One 10, e0141927 (2015).
38. Kreher, S. et al. Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA 111, E4513-E4522 (2014).
39. Dominguez, C. X. et al. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212, 2041-2056 (2015).
40. Barwick, B. G., Scharer, C. D., Bally, A. P. R. &Boss, J. M. Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation. Nat. Immunol. 17, 1216-1225 (2016).
41. Karwacz, K. et al. Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation. Nat. Immunol. 18, 412-421 (2017).
42. Audzevich, T., Pearce, G., Breucha, M., Günal, G. &Jessberger, R. Control of the STAT6-BCL6 antagonism by SWAP-70 determines IgE production. J. Immunol. 190, 4946-4955 (2013).
43. Ochiai, K. et al. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38, 918-929 (2013).
44. Kang, K. et al. Interferon-γ represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF. Immunity 47, 235-250 (2017).
45. Carotta, S. et al. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J. Exp. Med. 211, 2169-2181 (2014).
46. Lu, D. et al. The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. J. Exp. Med. 211, 2183-2198 (2014).
47. Sarra, M., Pallone, F. &Monteleone, G. Interleukin-21 in chronic inflammatory diseases. Biofactors 39, 368-373 (2013).
48. Eames, H. L., Corbin, A. L. &Udalova, I. A. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. Transl. Res. 167, 167-182 (2016).
49. Claes, N. et al. Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients. J. Immunol. 197, 4576-4583 (2016).
50. Wang, Z. et al. T-bet-expressing B cells are positively associated with Crohn's disease activity and support Th1 inflammation. DNA Cell Biol. 35, 628-635 (2016).
51. Biswas, P. S. et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120, 3280-3295 (2010).
52. Biswas, P. S., Kang, K., Gupta, S., Bhagat, G. &Pernis, A. B. A murine autoimmune model of rheumatoid arthritis and systemic lupus erythematosus associated with deregulated production of IL-17 and IL-21. Methods Mol. Biol 900, 233-251 (2012).
53. Minnich, M. et al. Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation. Nat. Immunol. 17, 331-343 (2016).